基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research interests
Associate Professor Barry Slobedman is head of the Cytomegalovirus (CMV) Research Group. Human CMV is a herpesvirus which infects a vast majority of the world¿s population, where it is a leading cause of opportunistic and congenital disease. Primary productive infection leads to a lifelong latent infection that is characterised by maintenance of the viral genome without infectious virus production. Periodically, the virus reactivates from latency and is shed in bodily secretions. Whilst primary and reactivated infections are usually mild or asymptomatic in healthy adults, primary infection is a major cause of serious congenital infection leading to still birth or neurological damage in children and reactivated infection is a major cause of life-threatening disease in immunosuppressed individuals, such as those with HIV AIDS and in allogeneic stem cell and solid organ transplant recipients.
The overall goal of the CMV Research Group is to define the mechanisms by which CMV causes life-threatening disease in these at-risk individuals, so as to provide a rational basis for the design of novel anti-viral therapeutics to prevent or treat CMV disease. The CMV Research Group consists of Postdocs as well as PhD and Honours students and positions are frequently available for those with a keen interest in biomedical research.
Associate Professor Barry Slobedman is head of the Cytomegalovirus (CMV) Research Group. Human CMV is a herpesvirus which infects a vast majority of the world¿s population, where it is a leading cause of opportunistic and congenital disease. Primary productive infection leads to a lifelong latent infection that is characterised by maintenance of the viral genome without infectious virus production. Periodically, the virus reactivates from latency and is shed in bodily secretions. Whilst primary and reactivated infections are usually mild or asymptomatic in healthy adults, primary infection is a major cause of serious congenital infection leading to still birth or neurological damage in children and reactivated infection is a major cause of life-threatening disease in immunosuppressed individuals, such as those with HIV AIDS and in allogeneic stem cell and solid organ transplant recipients.
The overall goal of the CMV Research Group is to define the mechanisms by which CMV causes life-threatening disease in these at-risk individuals, so as to provide a rational basis for the design of novel anti-viral therapeutics to prevent or treat CMV disease. The CMV Research Group consists of Postdocs as well as PhD and Honours students and positions are frequently available for those with a keen interest in biomedical research.
Research Interests
Papers共 104 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ISCIENCEno. 2 (2024): 108801-108801
Clinical & Translational Immunologyno. 12 (2023): e16815-e16815
FRONTIERS IN IMMUNOLOGY (2023): 1121714-1121714
mSphereno. 3 (2023)
The Journal of infectious diseases (2023)
Current Topics in Microbiology and Immunology (2022): 85-102
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn